Tasso Marketing
Ben Casavant, PhD, CEO of Tasso, named EY Entrepreneur Of The Year 2026 Mountain West finalist after global growth
Ben Casavant, PhD, co-founder and CEO of Tasso, Inc., was named a finalist for EY US’s Entrepreneur Of The Year 2026 Mountain West award after leading Tasso’s global expansion and development of patient-centric blood collection technologies used in 60+ countries and all 50 U.S. states.
Tasso, Inc. Renews SOC 2 Type 2 Certification Following Independent Audit by Prescient Assurance
Tasso, Inc. announced it renewed its SOC 2 Type 2 certification after an independent audit by Prescient Assurance that produced an unqualified (clean) opinion, reaffirming the company’s commitment to protecting patient and client data across its API and online platforms.
Neurogen Biomarking partners with Tasso to use needle-free blood collection for home-based Alzheimer’s testing
Neurogen Biomarking will integrate Tasso’s virtually painless, needle-free blood collection devices into its home-based Alzheimer’s testing service, pairing blood-based biomarker tests with digital cognitive assessments, in-home collection, lab processing, and telehealth review by neurologists.
Tasso, Inc. obtains Health Canada license and EU approvals to sell Tasso Mini in Canada, Italy, and Spain
Tasso, Inc. received Health Canada licensing and additional EU approvals allowing its Tasso Mini blood collection device to be sold in Canada, Italy, and Spain, expanding availability beyond its existing U.S. FDA 510(k) clearance and CE Marking. The Tasso Mini is designed for gentle, virtually painless sampling for sensitive or repeat-use patients and now matches the international availability of Tasso’s flagship Tasso+® device.
Tasso, Inc. renews SOC 2 Type II certification with unqualified opinion after Prescient Assurance audit
Tasso, Inc. renewed its SOC 2 Type II compliance certification with an unqualified (clean) opinion after an independent audit by Prescient Assurance, affirming its enterprise-level data security across platforms and APIs. The renewal underscores Tasso’s commitment to protecting sensitive patient data for its patient-centric blood collection solutions.
